Antikörper-Wirkstoff-Konjugat gegen HER2-positiven Brustkrebs
Crossref DOI link: https://doi.org/10.1007/s15013-014-0513-x
Published Online: 2014-08-28
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
pm,
Text and Data Mining valid from 2014-08-28
